Impaired dopamine release and uptake in R6/1 Huntington's disease model mice
dc.contributor.author | Ortiz, Andrea Naomi | |
dc.contributor.author | Kurth, Benjamin J. | |
dc.contributor.author | Osterhaus, Gregory L. | |
dc.contributor.author | Johnson, Michael A. | |
dc.date.accessioned | 2017-02-16T20:17:08Z | |
dc.date.available | 2017-02-16T20:17:08Z | |
dc.date.issued | 2011-03-29 | |
dc.identifier.citation | Ortiz, A. N., Kurth, B. J., Osterhaus, G. L., & Johnson, M. A. (2011). Impaired dopamine release and uptake in R6/1 Huntington’s disease model mice. Neuroscience Letters, 492(1), 11–14. http://doi.org/10.1016/j.neulet.2011.01.036 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/23196 | |
dc.description.abstract | Huntington’s disease (HD) is a progressive, neurodegenerative movement disorder. Here, we used fast-scan cyclic voltammetry to measure dopamine release and uptake in striatal brain slices from R6/1 HD model mice. Peak dopamine release ([DA]max) was significantly diminished in R6/1 mice (52% of wild-type at 24 weeks of age). Similarly, dopamine released per locally applied electrical stimulus pulse ([DA]p), which is [DA]max corrected for uptake and electrode performance, was also diminished in R6/1 mice (43% of wild-type by 24 weeks of age). Moreover, Vmax, the maximum rate of dopamine uptake, obtained by modeling the stimulated release plots, was decreased at 16 and 24 weeks of age in R6/1 mice (51 and 48% of wild-type, respectively). Thus, impairments in both dopamine release and uptake appear to progress in an age-dependent manner in R6/1 mice. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Dopamine | en_US |
dc.subject | Voltammetry | en_US |
dc.subject | Huntington’s disease | en_US |
dc.subject | R6/1 mice | en_US |
dc.subject | Release | en_US |
dc.subject | Uptake | en_US |
dc.title | Impaired dopamine release and uptake in R6/1 Huntington's disease model mice | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Ortiz, Andrea N. | |
kusw.kuauthor | Kurth, Benjamin J. | |
kusw.kuauthor | Osterhaus, Gregory L. | |
kusw.kuauthor | Johnson, Michael A. | |
kusw.kudepartment | Chemistry | en_US |
kusw.oanotes | Per SHERPA/RoMEO 2/16/2017: Author's Pre-print: green tick author can archive pre-print (ie pre-refereeing) Author's Post-print: green tick author can archive post-print (ie final draft post-refereeing) Publisher's Version/PDF: cross author cannot archive publisher's version/PDF General Conditions: Authors pre-print on any website, including arXiv and RePEC Author's post-print on author's personal website immediately Author's post-print on open access repository after an embargo period of between 12 months and 48 months Permitted deposit due to Funding Body, Institutional and Governmental policy or mandate, may be required to comply with embargo periods of 12 months to 48 months Author's post-print may be used to update arXiv and RepEC Publisher's version/PDF cannot be used Must link to publisher version with DOI Author's post-print must be released with a Creative Commons Attribution Non-Commercial No Derivatives License | en_US |
dc.identifier.doi | 10.1016/j.neulet.2011.01.036 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.